GHRP-6Explore study findings
Why preventing a raised scar differs from reversing one
2 numbered sourcesSource years 2018, 2021
Short chains of amino acids joined by peptide bonds can act as biological signals. GHRP-6 is a synthetic six-residue peptide that activates the ghrelin receptor and promotes growth hormone release in experimental settings. An animal study asked whether exposure to GHRP-6 changed the development of a raised scar or the appearance of an already mature scar. [1, 2]
No recent primary study directly testing those two scar questions was identified. In an older study, researchers used a rabbit model of hypertrophic scarring. A hypertrophic scar grows thicker and higher than the surrounding skin because of excess material deposited during healing. The researchers ran separate experiments to examine scar development after injury and to test effects on established scars. They compared GHRP-6 with control preparations and used measurements including ultrasound and examination of tissue sections. [2]
The authors reported fewer hypertrophic scars when GHRP-6 was applied during the development stage of the model. The mature scars did not show a statistically clear reversal in the other experiment. These are different questions about two points in healing. Once a scar has formed, its tissue structure and the cells producing it may differ from those present just after injury. The researchers also looked for early protein changes, which gave them clues about processes to investigate in further work. [2]
This is older direct evidence in rabbits. It does not establish the same effects in human skin or show improvement in a patient outcome such as comfort or mobility. The comparison helps explain why a study about an early wound response cannot by itself substantiate a claim about treating an established scar. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
